Early Pancreatic Cancer Detection Improved with cfDNA Model-CD-AACR - Elizabeth McKenna @elizsmckenna.bsky.social oncodaily.com/voices/377561 #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PancreaticCancer

Join us in downtown Washington, DC next Saturday October 4th for the DC Lung Cancer Conference, an IASLC endorsed, 1-day CME meeting covering updates in lung cancer, featuring 58 thoughtful & dynamic faculty members. #DCLung25 Register today at medstarhealth.org/dclung25

Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series - Vivek Subbiah @viveksubbiah.bsky.social oncodaily.com/voices/vivek... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Thanks to all who made our Chicago group meeting a success! It went by too quickly, but it’s always refreshing to see our #SWOGonc community in person. We're grateful for our donors 🙏 And for those who picked up some new @swog.org swag, we’re excited to see where you’ll be spotted wearing it!

A Meaningful Week of Science at the WCLC25 - Narjust Florez @narjustflorezmd.bsky.social oncodaily.com/voices/narju... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25

Robin Zon Has Been Promoted to Chair of ASCO Society Board @ascocancer.bsky.social oncodaily.com/career/robin... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO

‘One jab will do the job’: Pakistan begins rollout of HPV vaccine to millions of girls

Partitioning obesity by genomics, proteomics and health outcomes from >450,000 UK Biobank @naturemedicine.bsky.social —A protective subtype vs cardiometabolic diseases (GRS BFP) and —A risk subtype for these diseases (GRS uncoupling) GRS-genomic risk score nature.com/articles/s41...

1/ Thrilled to share that my main PhD article has just been published in Nature Human Behaviour! 🎉 👉 “A randomised controlled trial on the effect of administrative burden and information costs on social inequalities in early childcare access in France” rdcu.be/eFAEA

Caring Beyond the Diagnosis: UICC’s Global Impact on Cancer Support @uiccofficial.bsky.social oncodaily.com/voices/uicc-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #UICC

On the Frontlines: Promoting Awareness of Young Lung Cancer - Narjust Florez @narjustflorezmd.bsky.social oncodaily.com/voices/narju... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #YoungLungCancer

Dr. Andy Wagner discusses advances and the ongoing research happening at @danafarber.bsky.social to better diagnose and treat cancer to improve outcomes for patients. Check out the story from Spectrum News 1 Worcester that aired as part of a #StandUp2Cancer special. ➡️ bit.ly/4mP2ZsZ

Moving to places that encourage more walking leads to more walking… @nature.com

Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial - The Lancet www.thelancet.com/journals/lan...

Can Macrophages Revolutionize Cancer Immunotherapy? - Yan Leyfman @yleyfman.bsky.social oncodaily.com/blog/yan-ley... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #IO #Macrophages #CART

A pleasure to present alongside Drs @michael-jefford.bsky.social #DrLarissaNekhlyudov at today’s #MASCC25 Survivorship Workshop! Thank you to the attendees for your participation! @cancercaremascc.bsky.social

New data presented at #ASCO25 today by @danafarber.bsky.social's Sara Tolaney, MD, showed an ADC-immunotherapy combination resulted in durable responses with improved PFS among patients with metastatic TNBC when compared to standard treatment. ➡️ bit.ly/3HdmbB2

Thank you @maryamlustberg.bsky.social for sharing updates from @cancercaremascc.bsky.social to the @pallonccop.bsky.social !! Looking forward to participating/promoting the many great programs and initiatives! #oncsky #oncologynursing

NEWS FROM INDUSTRY Astra Zeneca reports that the POTOMAC Phase III trial demonstrated that adding 1yr durvalumab to standard Bacillus Calmette-Guérin induction and maintenance therapy significantly improved DGS in high-risk non-muscle-invasive #BladderCancer www.astrazeneca.com/media-centre...

Join nine clinical IO experts May 8! The SITC ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines program offers discussions on personalized cancer vaccines and free CME credits. Advance your knowledge: www.sitcancer.org/education/ac... @aporia64.bsky.social @eladsharonmd.bsky.social 🧪

Most vaccines don’t trigger mucosal IgA—a key airway defense Clever new Nat Comm study from 🇳🇴 solves that by fusing antigens to albumin, which uses FcRn pathway to cross the nasal barrier Result: a potent intranasal vaccine that protects vs. both flu and SARS-CoV-2 www.nature.com/articles/s41...

About to speak at the @theaacr.bsky.social annual meeting on side effects associated with cancer immunotherapy! If you are in Chicago, please come to S403b! It’s the place to be!

Our #TranslationalMedicine Link of the Week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: Microbiota-Centered Interventions to Boost Immune Checkpoint Blockade Therapies doi.org/10.1084/jem....

#myeloMATCH sub-study MM1OA-S03 is open! Patients registered to MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned. Randomized to venetoclax + ASTX727 w/wo enasidenib. swog.org/clinical-trials/MM1OA-S03 @beatalleukemia.bsky.social

Complacency = Complicity

Clifton Mo, MD, provides an update on our ongoing clinical research to advance cutting-edge therapies for patients with multiple myeloma. https://bit.ly/3FfiSbx

S2212 SCARLET is a randomized @swog.org ph 3 trial of treatment de-escalation in early-stage #triplenegative #breastcancer, comparing neoadjuvant immunotherapy + chemo w/wo anthracyclines. #TNBC SWOG.org/clinical-trials/S2212 PI: Priyanka Sharma, MD @ibcresearch1.bsky.social @raalbany.bsky.social

Shortage Of Oncologists & Hematologists In US Projected To Exceed 2,000 By End Of Year @ascocancer.bsky.social @cliffordhudis.bsky.social @gohealio.bsky.social www.healio.com/news/hematol...

Our #TranslationalMedicine link of the week (#2 of 2), chosen by @swog.org's Lee Ellis, MD & Jimmy Rae, PhD: Integrating Artificial Intelligence in Drug Discovery and Early Drug Development: A Transformative Approach doi.org/10.1186/s403...

A study in Nature Neuroscience shows that brain inflammation in COVID-19 correlates with viral load, systemic inflammation and virus-sensing pattern recognition receptors. Microglial dysfunction occurs at sites of vascular inflammation with myelin injury and synapse loss. 🧪

Our group chair's blog: The S2212 De-Escalation Trial: Only in Public-Powered Research S2212 in triple-negative #breastcancer collects patient-reported outcomes to tell us whether shorter, anthracycline-free treatment is efficacious & easier for patients #bcsm www.swog.org/news-events/...

Researchers from Ohio State University Comprehensive Cancer Center-James Cancer Hospital, led by Dr. Marcos De Lima, have shed light on a critical aspect of CAR-T therapy 🧬—long-term complications.

New findings from Dr. Fobert Ferris & team of UNC Lineberger Comprehensive Cancer Center reveal how neoadjuvant combination ICI reshapes CD8+ T cell responses in head & neck cancer! 👇

Incredible story, very well told. At the intersection of purpose-driven scientific research, dedicated federal employees working tirelessly without credit for the public good, rare diseases under radar of the power of the market, and “healthcare” in the US. Sharing as a gift article: wapo.st/3DyAWgz

Great turnout for #StandUpForScience in #Boston. This city is home to some of the greatest research institutions and hospitals in the world. We will not be silenced.

Packed house at #BTOG25’s SC lung cancer session Dr @stephenvliu.bsky.social talks of need to ID those that do/don’t derive benefit, find biomarkers, review optimal sequencing & better understand evolving biology of #SCLC. Describes SCLC in ppl w no/light smoking history. #LCSM @btog.bsky.social

Congrats to Dr. Jeff Rathmell UChicago names Jeffrey Rathmell, PhD, as Chair of the Ben May Department for Cancer Research biologicalsciences.uchicago.edu/news/jeffrey...

Now out in @jmirpub.bsky.social: a report on the Cancer Briefs project led by @swog.org patient advocate Jonathan Sommers. Infotainment video to increase awareness of a #ClinicalTrial. Read more @fredhutch.bsky.social

Our #TranslationalMedicine link of the week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: Prediction of Checkpoint Inhibitor Immunotherapy Efficacy for Cancer Using Routine Blood Tests and Clinical Data doi.org/10.1038/s415...

🩸🧬 Promising Results for Sickle Cell Transplant! A new study shows HLA-haploidentical bone marrow transplantation (BMT) with posttransplant cyclophosphamide may be a curative option for adults with sickle cell disease. ✅

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures www.nature.com/articles/s41...

Burden of Comorbid Conditions Among Individuals Screened for Lung Cancer jamanetwork.com/journals/jam...

Interesting results presented by Elizabeth Krantz from @joshhillmd.bsky.social team @fredhutch.bsky.social @astct.bsky.social Tandem2025. Overall antibody levels are low in CAR T recipients. Re-vaccination is important. The Boonya lab collaborated on the B cell analysis.

There’s been much discussion about CAR T for severe autoimmune disease, incl. lupus & MS. What can we learn about how that might work from patients who have both cancer & autoimmune disease and get B-/plasma-cell directed CAR T? From Jennifer Huang @fredhutch.bsky.social #Tandem25 #OncSky #RheumSky

Great @ascocancer.bsky.social #GU25 catching up with many friends ! @jrgralow.bsky.social

Our @swog.org group chair's blog: *Nothing but Blue Skies (Thinking about Social Media)* Like so many others from the #MedTwitter realm, SWOG has expanded to #Bluesky. If you're curious, here's detail on how to explore the platform, and even a SWOG starter pack. www.swog.org/news-events/...

I am pleased to share a copy of the ad for our open faculty search at @BrownUniversity’s #LegorretaCancerCenter in Rhode Island. @ShiOnaCo @rwsobol @SenduraiMani @LiangChengMD @DawsonStemCell @SeanLawler20 @LanlanZhou @ClubDanio

Amazing showing from my team (ex-NIH, now VT) at #tandem25 - five presentations over the next two days!! Dr. Gege Gui and I both talk tomorrow, and Rasha Al-Ali, Jesse Tettero, and Laura Dillon all have presentations on Thursday. @astct.bsky.social @cibmtr.bsky.social @fralinbiomed.bsky.social

Our paper in @nature.com is finally published: a prospective trial of a personalized Neoantigen Vaccine in Kidney Cancer www.nature.com/articles/s41... This is teamwork with @danafarber.bsky.social @yalecancer.bsky.social @harvardmed.bsky.social + Wu lab www.nature.com/articles/s41...

The promise of a personalized (neoantigen) vaccine for treating cancer, as seen by immune response bolstering against renal cell carcinoma in a Phase 1 trial nature.com/articles/d41... nature.com/articles/s41...